Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease

Aging is one of the main risk factors for cardiovascular disease, resulting in a progressive organ and cell decline. This study evaluated a possible joint impact of two emerging hallmarks of aging, leucocyte telomere length (LTL) and common mitochondrial DNA deletion (mtDNA<sup>4977</sup>...

Full description

Bibliographic Details
Main Authors: Cecilia Vecoli, Andrea Borghini, Silvia Pulignani, Antonella Mercuri, Stefano Turchi, Eugenio Picano, Maria Grazia Andreassi
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/21/5508
id doaj-9491879c4ff648189c65c23f5f7028a9
record_format Article
spelling doaj-9491879c4ff648189c65c23f5f7028a92020-11-25T01:18:38ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-11-012021550810.3390/ijms20215508ijms20215508Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery DiseaseCecilia Vecoli0Andrea Borghini1Silvia Pulignani2Antonella Mercuri3Stefano Turchi4Eugenio Picano5Maria Grazia Andreassi6CNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyAging is one of the main risk factors for cardiovascular disease, resulting in a progressive organ and cell decline. This study evaluated a possible joint impact of two emerging hallmarks of aging, leucocyte telomere length (LTL) and common mitochondrial DNA deletion (mtDNA<sup>4977</sup>), on major adverse cardiovascular events (MACEs) and all-cause mortality in patients with coronary artery disease (CAD). We studied 770 patients (673 males, 64.8 &#177; 8.3 years) with known or suspected stable CAD. LTL and mtDNA<sup>4977</sup> deletion were assessed in peripheral blood using qRT-PCR. During a median follow-up of 5.4 &#177; 1.2 years, MACEs were 140 while 86 deaths were recorded. After adjustments for confounding risk factors, short LTLs and high mtDNA<sup>4977</sup> deletion levels acted independently as predictors of MACEs (HR: 2.2, 95% CI: 1.2&#8722;3.9, <i>p</i> = 0.01 and HR: 1.7, 95% CI: 1.1&#8722;2.9, <i>p</i> = 0.04; respectively) and all-cause mortality events (HR: 2.1, 95% CI: 1.1&#8722;4.6, <i>p</i> = 0.04 and HR: 2.3, 95% CI: 1.1&#8722;4.9, <i>p</i> = 0.02; respectively). Patients with both short LTLs and high mtDNA<sup>4977</sup> deletion levels had an increased risk for MACEs (HR: 4.3; 95% CI: 1.9&#8722;9.6; <i>p</i> = 0.0006) and all-cause mortality (HR: 6.0; 95% CI: 2.0&#8722;18.4; <i>p</i> = 0.001). The addition of mtDNA<sup>4977</sup> deletion to a clinical reference model was associated with a significant net reclassification improvement (NRI = 0.18, <i>p</i> = 0.01). Short LTL and high mtDNA<sup>4977</sup> deletion showed independent and joint predictive value on adverse cardiovascular outcomes and all-cause mortality in patients with CAD. These findings strongly support the importance of evaluating biomarkers of physiological/biological age, which can predict disease risk and mortality more accurately than chronological age.https://www.mdpi.com/1422-0067/20/21/5508major adverse cardiac eventsall-cause mortalityleucocyte telomere lengthmtdna<sup>4977</sup> common deletioncoronary artery disease
collection DOAJ
language English
format Article
sources DOAJ
author Cecilia Vecoli
Andrea Borghini
Silvia Pulignani
Antonella Mercuri
Stefano Turchi
Eugenio Picano
Maria Grazia Andreassi
spellingShingle Cecilia Vecoli
Andrea Borghini
Silvia Pulignani
Antonella Mercuri
Stefano Turchi
Eugenio Picano
Maria Grazia Andreassi
Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
International Journal of Molecular Sciences
major adverse cardiac events
all-cause mortality
leucocyte telomere length
mtdna<sup>4977</sup> common deletion
coronary artery disease
author_facet Cecilia Vecoli
Andrea Borghini
Silvia Pulignani
Antonella Mercuri
Stefano Turchi
Eugenio Picano
Maria Grazia Andreassi
author_sort Cecilia Vecoli
title Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
title_short Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
title_full Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
title_fullStr Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
title_full_unstemmed Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
title_sort independent and combined effects of telomere shortening and mtdna<sup>4977</sup> deletion on long-term outcomes of patients with coronary artery disease
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2019-11-01
description Aging is one of the main risk factors for cardiovascular disease, resulting in a progressive organ and cell decline. This study evaluated a possible joint impact of two emerging hallmarks of aging, leucocyte telomere length (LTL) and common mitochondrial DNA deletion (mtDNA<sup>4977</sup>), on major adverse cardiovascular events (MACEs) and all-cause mortality in patients with coronary artery disease (CAD). We studied 770 patients (673 males, 64.8 &#177; 8.3 years) with known or suspected stable CAD. LTL and mtDNA<sup>4977</sup> deletion were assessed in peripheral blood using qRT-PCR. During a median follow-up of 5.4 &#177; 1.2 years, MACEs were 140 while 86 deaths were recorded. After adjustments for confounding risk factors, short LTLs and high mtDNA<sup>4977</sup> deletion levels acted independently as predictors of MACEs (HR: 2.2, 95% CI: 1.2&#8722;3.9, <i>p</i> = 0.01 and HR: 1.7, 95% CI: 1.1&#8722;2.9, <i>p</i> = 0.04; respectively) and all-cause mortality events (HR: 2.1, 95% CI: 1.1&#8722;4.6, <i>p</i> = 0.04 and HR: 2.3, 95% CI: 1.1&#8722;4.9, <i>p</i> = 0.02; respectively). Patients with both short LTLs and high mtDNA<sup>4977</sup> deletion levels had an increased risk for MACEs (HR: 4.3; 95% CI: 1.9&#8722;9.6; <i>p</i> = 0.0006) and all-cause mortality (HR: 6.0; 95% CI: 2.0&#8722;18.4; <i>p</i> = 0.001). The addition of mtDNA<sup>4977</sup> deletion to a clinical reference model was associated with a significant net reclassification improvement (NRI = 0.18, <i>p</i> = 0.01). Short LTL and high mtDNA<sup>4977</sup> deletion showed independent and joint predictive value on adverse cardiovascular outcomes and all-cause mortality in patients with CAD. These findings strongly support the importance of evaluating biomarkers of physiological/biological age, which can predict disease risk and mortality more accurately than chronological age.
topic major adverse cardiac events
all-cause mortality
leucocyte telomere length
mtdna<sup>4977</sup> common deletion
coronary artery disease
url https://www.mdpi.com/1422-0067/20/21/5508
work_keys_str_mv AT ceciliavecoli independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease
AT andreaborghini independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease
AT silviapulignani independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease
AT antonellamercuri independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease
AT stefanoturchi independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease
AT eugeniopicano independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease
AT mariagraziaandreassi independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease
_version_ 1725141477796872192